Literature DB >> 10781702

Who becomes depressed? The Islington community study of older people.

G Livingston1, V Watkin, B Milne, M V Manela, C Katona.   

Abstract

BACKGROUND: Depression in older people is common and debilitating and associated with physical ill health. This is the first study of risk factors for depression in a representative sample of older people selected for high vulnerability because of physical ill health.
METHOD: Subjects identified in an epidemiological community survey of morbidity in people > or =65 years old, who had activity limitation (ADL) but no psychiatric morbidity were reinterviewed after 3 years.
RESULTS: 79 (90%) of subjects were interviewed. Ten percent developed pervasive depression and 24% screened positive for depression. This latter group were more likely to consult doctors than others with similar levels of disability (P<0.005) mainly because of an acute physical illness. Frequent pain was associated with the development of depression (P<0.02).
CONCLUSION: Older people who are ADL limited are known to be at high risk for depression. For the majority who do not become depressed, chronicity of illness does not lead to depression. Those who become depressed are most likely to be those with an acute illness and those who are in pain. They will usually increase their consultation rate with doctors but will not complain of depression. They may be undertreated for both pain and depression. Further studies are needed to confirm other risk factors.

Entities:  

Mesh:

Year:  2000        PMID: 10781702     DOI: 10.1016/s0165-0327(99)00103-2

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  12 in total

1.  [Relation between certain diseases and frequency of depression in geriatric patients].

Authors:  V Zietemann; P Zietemann; R Weitkunat; A Kwetkat
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

2.  Heterogeneous depression responses to chronic pain onset among middle-aged adults: a prospective study.

Authors:  Zhuoying Zhu; Isaac R Galatzer-Levy; George A Bonanno
Journal:  Psychiatry Res       Date:  2014-03-11       Impact factor: 3.222

3.  Why treat insomnia?

Authors:  Sara E Matteson-Rusby; Wilfred R Pigeon; Philip Gehrman; Michael L Perlis
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 4.  The role of psychiatric disorders in fibromyalgia.

Authors:  J McBeth; A J Silman
Journal:  Curr Rheumatol Rep       Date:  2001-04       Impact factor: 4.592

5.  Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort?

Authors:  Wilfred R Pigeon; Mark Hegel; Jürgen Unützer; Ming-Yu Fan; Michael J Sateia; Jeffrey M Lyness; Cindy Phillips; Michael L Perlis
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

6.  Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study.

Authors:  Hyong Jin Cho; Helen Lavretsky; Richard Olmstead; Myron J Levin; Michael N Oxman; Michael R Irwin
Journal:  Am J Psychiatry       Date:  2008-09-02       Impact factor: 18.112

7.  The Effect of Sleep Disturbances on Major Depressive Disorder.

Authors:  Wilfred R Pigeon
Journal:  Depress Mind Body       Date:  2009

8.  The high prevalence of obsessive-compulsive disorder in patients with chronic pain.

Authors:  Ali Mehraban; Jamal Shams; Sirous Moamenzade; Seyed Mehdi Samimi; Sahar Rafiee; Fatemeh Zademohamadi
Journal:  Iran J Psychiatry       Date:  2014-10

9.  The effect of the traditional living arrangement, anpakkori, on depressive symptoms in elderly people residing on jeju island.

Authors:  Eun-Hui Oh; Moon-Doo Kim; Seong-Chul Hong
Journal:  Psychiatry Investig       Date:  2009-08-22       Impact factor: 2.505

10.  Spatial Variability of Geriatric Depression Risk in a High-Density City: A Data-Driven Socio-Environmental Vulnerability Mapping Approach.

Authors:  Hung Chak Ho; Kevin Ka-Lun Lau; Ruby Yu; Dan Wang; Jean Woo; Timothy Chi Yui Kwok; Edward Ng
Journal:  Int J Environ Res Public Health       Date:  2017-08-31       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.